Literature DB >> 19705475

Muscle after spinal cord injury.

Bo Biering-Sørensen1, Ida Bruun Kristensen, Michael Kjaer, Fin Biering-Sørensen.   

Abstract

The morphological and contractile changes of muscles below the level of the lesion after spinal cord injury (SCI) are dramatic. In humans with SCI, a fiber-type transformation away from type I begins 4-7 months post-SCI and reaches a new steady state with predominantly fast glycolytic IIX fibers years after the injury. There is a progressive drop in the proportion of slow myosin heavy chain (MHC) isoform fibers and a rise in the proportion of fibers that coexpress both the fast and slow MHC isoforms. The oxidative enzymatic activity starts to decline after the first few months post-SCI. Muscles from individuals with chronic SCI show less resistance to fatigue, and the speed-related contractile properties change, becoming faster. These findings are also present in animals. Future studies should longitudinally examine changes in muscles from early SCI until steady state is reached in order to determine optimal training protocols for maintaining skeletal muscle after paralysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705475     DOI: 10.1002/mus.21391

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  69 in total

1.  Reduced voluntary drive during sustained but not during brief maximal voluntary contractions in the first dorsal interosseous weakened by spinal cord injury.

Authors:  Roeland F Prak; Marwah Doestzada; Christine K Thomas; Marga Tepper; Inge Zijdewind
Journal:  J Appl Physiol (1985)       Date:  2015-09-24

Review 2.  Effects of Use and Disuse on Non-paralyzed and Paralyzed Skeletal Muscles.

Authors:  David R Dolbow; Ashraf S Gorgey
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

3.  Feasibility of overnight electrical stimulation-induced muscle activation in people with a spinal cord injury. A Pilot study.

Authors:  Christof A J Smit; Frank Berenpas; Sonja de Groot; Janneke M Stolwijk-Swuste; Thomas W J Janssen
Journal:  Spinal Cord Ser Cases       Date:  2020-01-24

4.  Molecular Changes in Sub-lesional Muscle Following Acute Phase of Spinal Cord Injury.

Authors:  Nakul P Thakore; Supriti Samantaray; Sookyoung Park; Kenkichi Nozaki; Joshua A Smith; April Cox; James Krause; Naren L Banik
Journal:  Neurochem Res       Date:  2015-08-20       Impact factor: 3.996

Review 5.  Effects of spinal cord injury on body composition and metabolic profile - part I.

Authors:  Ashraf S Gorgey; David R Dolbow; James D Dolbow; Refka K Khalil; Camilo Castillo; David R Gater
Journal:  J Spinal Cord Med       Date:  2014-07-07       Impact factor: 1.985

6.  Adaptive muscle plasticity of a remaining agonist following denervation of its close synergists in a model of complete spinal cord injury.

Authors:  Charline Dambreville; Jérémie Charest; Yann Thibaudier; Marie-France Hurteau; Victoria Kuczynski; Guillaume Grenier; Alain Frigon
Journal:  J Neurophysiol       Date:  2016-06-29       Impact factor: 2.714

7.  Effects of resistance-guided high intensity interval functional electrical stimulation cycling on an individual with paraplegia: A case report.

Authors:  David R Dolbow; Daniel P Credeur
Journal:  J Spinal Cord Med       Date:  2017-09-04       Impact factor: 1.985

Review 8.  Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.

Authors:  Jared Talbot; Lisa Maves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-05-19       Impact factor: 5.814

9.  Motoneuron Death after Human Spinal Cord Injury.

Authors:  Robert M Grumbles; Christine K Thomas
Journal:  J Neurotrauma       Date:  2016-08-25       Impact factor: 5.269

10.  Influence of injection of Chinese botulinum toxin type A on the histomorphology and myosin heavy chain composition of rat gastrocnemius muscles.

Authors:  Bin Hong; Min Chen; Xing-yue Hu
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.